News

Find News

Filter articles

Applied Filters

Showing 91 to 100 of 232 results

GSK triumphs in trademark suit in India

India09-11-2016

Pharmaceutical company GSK has triumphed in a trademark infringement dispute in India.

Sun Pharma to acquire Ocular Technologies for $40m

India03-11-2016

India-based pharmaceutical company Sun Pharma has agreed to acquire Ocular Technologies for $40 million.

Astellas to acquire Ganymed for €422m

Germany, Japan31-10-2016

Japanese pharmaceutical company Astellas and German biopharmaceutical company Ganymed have entered into an agreement under which Astellas will acquire Ganymed for €422 million.

Sunovion Pharmaceuticals acquires Cynapsus for $653m

Canada, Japan, US26-10-2016

Japanese company Sumitomo Dainippon Pharma’s US subsidiary, Sunovion Pharmaceuticals, has completed the acquisition of Cynapsus Therapeutics.

Novartis wins growth hormone domain dispute

International20-10-2016

Healthcare company Novartis has won a domain name dispute at the World Intellectual Property Organization Arbitration and Mediation Center.

Sun Pharma collaborates with ICGEB to develop dengue vaccine

India19-10-2016

Indian pharmaceutical company Sun Pharma and the International Centre for Genetic Engineering and Biotechnology have entered into an exclusive collaboration to develop a novel dengue vaccine for India and global markets.

Janssen sells five drugs for $155m

India12-10-2016

India-based Piramal Enterprises has signed an agreement with Belgian pharmaceutical company Janssen under which Piramal will acquire five anaesthesia and pain management products for $155 million in cash.

AstraZeneca to divest Rhinocort Aqua rights outside US

International10-10-2016

AstraZeneca and Cilag, an affiliate of Johnson & Johnson, have entered into an agreement for AstraZeneca to divest the rights to Rhinocort Aqua outside the US.

$2m worth of fake drugs seized in Myanmar

Myanmar05-10-2016

Myanmar authorities have seized K2.8 billion worth of counterfeit and expired drugs.

Glenmark partners with Particle Sciences in Abraxane generic deal

India27-09-2016

India-based pharmaceutical company Glenmark has signed a wide-ranging drug agreement with Particle Sciences, a provider of drug development services.

Showing 91 to 100 of 232 results

LSIPR